Alnylam Pharmaceuticals, Inc.
ALNY· Nasdaq
ALNYAlnylam Pharmaceuticals, Inc.
Filed Aug 7, 2015 · 10-Q · 38 days after period end · 0001193125-15-282067
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$71.78M | -$44.07M | -$18.17M | -$12.96M |
| EPS Diluted | -$0.85 | -$0.58 | -$0.29 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alnylam Pharmaceuticals, Inc. · CIK 1178670 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 7, 2015 · 38 d after period end
